George A. Samuel III - General Counsel and Secretary at Lineage Cell Therapeutics, Inc.

Insider Transactions and Holdings

Entity Type
Individual
Role
General Counsel and Secretary
Stock Symbol
LCTX on NYSE
All Insider Reports
All Insider Reports

George A. Samuel III - trading volume in the past year for Lineage Cell Therapeutics, Inc.

Holdings reported by George A. Samuel III for Lineage Cell Therapeutics, Inc.

Security Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Common Shares 25.8K $16.8K $0.65 Feb 11, 2025 Direct
Employee Stock Option (Right to Buy) 750K Mar 10, 2025 Direct Common Shares
Restricted Stock Units 6.08K Feb 11, 2025 Direct Common Shares

Transactions reported by George A. Samuel III for Lineage Cell Therapeutics, Inc.

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.